tiprankstipranks
Trending News
More News >
Resmed (RMD)
NYSE:RMD
US Market
Advertisement

Resmed (RMD) Income Statement

Compare
1,121 Followers

Resmed Income Statement

Last quarter (Q4 2025), Resmed's total revenue was $1.35B, an increase of 10.20% from the same quarter last year. In Q4, Resmed's net income was $379.70M. See Resmed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 5.15B$ 4.69B$ 4.22B$ 3.58B$ 3.20B
Gross Profit
$ 3.05B$ 2.66B$ 2.36B$ 2.02B$ 1.84B
Operating Expenses
$ 1.37B$ 1.34B$ 1.22B$ 1.02B$ 935.42M
Depreciation and Amortization
$ 235.81M$ 216.21M$ 196.52M$ 193.84M$ 191.52M
EBITDA
$ 1.91B$ 1.53B$ 1.36B$ 1.18B$ 1.10B
Operating Income
$ 1.69B$ 1.32B$ 1.13B$ 1.00B$ 903.68M
Other Income/Expenses
$ -9.83M$ -55.09M$ -30.21M$ -39.80M$ -20.02M
Pretax Income
$ 1.68B$ 1.26B$ 1.10B$ 960.48M$ 883.66M
Net Income
$ 1.40B$ 1.02B$ 897.56M$ 779.44M$ 474.50M
Per Share Metrics
Basic EPS
$ 9.55$ 6.94$ 6.12$ 5.34$ 3.27
Diluted EPS
$ 9.51$ 6.92$ 6.09$ 5.30$ 3.24
Weighted Average Shares Outstanding
146.72M 147.02M 146.76M 146.07M 145.31M
Weighted Average Shares Outstanding (Diluted)
147.34M 147.55M 147.46M 147.04M 146.45M
Currency in USD

Resmed Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis